Status:
COMPLETED
Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Conjunctivitis, Allergic
Eligibility:
All Genders
10+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate whether bepotastine besilate ophthalmic solution is effective in the treatment of acute allergic conjunctivitis
Eligibility Criteria
Inclusion
- At least 10 years of age \& either sex, any race
- Willing and able to follow all instructions and attend all study visits
- Positive history of ocular allergies
Exclusion
- Have planned surgery during trial period
- Female currently pregnant, planning a pregnancy, or lactating
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT00424398
Start Date
February 1 2007
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISTA Pharmaceuticals, Inc.
Irvine, California, United States, 92630